Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition

Food Drug Law J. 1999;54(2):243-4.

Author

K J Kraushaar¹

Affiliation

¹ Consumer Healthcare Products Association (CHPA), Washington, D.C., USA

PMID: 11758581

No abstract available

MeSH terms

Drug Approval
Drug Industry / legislation & jurisprudence*
Drug Prescriptions
Drugs, Generic
Economic Competition*
Humans
Marketing of Health Services*
Nonprescription Drugs
Product Labeling / legislation & jurisprudence
United States
United States Food and Drug Administration

Substances

Drugs, Generic
Nonprescription Drugs